Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis

Background: The acute phase response is a major pathophysiologic phenomena that accompanies inflammation whether acute or chronic. The complements 3 (C3), complement4 (C4) and C-reactive protein (CRP) are positive acute phase proteins (+ve APPs) their production is increased by hepatocyte in osteoar...

Full description

Bibliographic Details
Main Author: Kismat M. Turki
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2008-10-01
Series:مجلة كلية الطب
Subjects:
Online Access:http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1266
_version_ 1797368746219667456
author Kismat M. Turki
author_facet Kismat M. Turki
author_sort Kismat M. Turki
collection DOAJ
description Background: The acute phase response is a major pathophysiologic phenomena that accompanies inflammation whether acute or chronic. The complements 3 (C3), complement4 (C4) and C-reactive protein (CRP) are positive acute phase proteins (+ve APPs) their production is increased by hepatocyte in osteoarthritis (OA). Chloroquine (CQ) which is a diprotic weak base traditionally used to treat malaria.Todate, the phosphate salt of CQ is used to decrease +ve APPs. Objective: To evaluate the role of chloroquine phosphate on acute phase proteins C3, C4 and Creactive protein in patients with knee OA. Subjects and methods :A total of seventy four patients (45 female and 29male) were selected randomly from the outpatients clinic in Baghdad teaching Hospital, Medical City, Baghdad suffering from knee OA were treated with oral dosage form of CQP for one month, twice daily. The levels of C3, C4 and C-reactive protein in serum of all patients were measured before and after treatment using ELISA technique.The serum level of C3, C4 and C-RP were calculated as mean ± standard error of mean (SEM); paired t-test was used; S= significant, P value < 0.05 Results :The levels of C3, C4 and C-RP were significantly reduced (P< 0.05) in serum of all patients after treatment with CQP for one month. Conclusion :CQP is a disease modifying anti rheumatic drug (DMARD) used for patients suffering from KOA in order to reduce their C3, C4 and C-RP value and improves the disease status.
first_indexed 2024-03-08T17:37:11Z
format Article
id doaj.art-a2a71d62b6aa42db9602058274addadc
institution Directory Open Access Journal
issn 0041-9419
2410-8057
language English
last_indexed 2024-03-08T17:37:11Z
publishDate 2008-10-01
publisher College of Medicine University of Baghdad
record_format Article
series مجلة كلية الطب
spelling doaj.art-a2a71d62b6aa42db9602058274addadc2024-01-02T11:45:11ZengCollege of Medicine University of Baghdadمجلة كلية الطب0041-94192410-80572008-10-0150310.32007/1266%g400-402Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritisKismat M. Turki0٭Baghdad University, College of Medicine, Department of Physiological Chemistry.Background: The acute phase response is a major pathophysiologic phenomena that accompanies inflammation whether acute or chronic. The complements 3 (C3), complement4 (C4) and C-reactive protein (CRP) are positive acute phase proteins (+ve APPs) their production is increased by hepatocyte in osteoarthritis (OA). Chloroquine (CQ) which is a diprotic weak base traditionally used to treat malaria.Todate, the phosphate salt of CQ is used to decrease +ve APPs. Objective: To evaluate the role of chloroquine phosphate on acute phase proteins C3, C4 and Creactive protein in patients with knee OA. Subjects and methods :A total of seventy four patients (45 female and 29male) were selected randomly from the outpatients clinic in Baghdad teaching Hospital, Medical City, Baghdad suffering from knee OA were treated with oral dosage form of CQP for one month, twice daily. The levels of C3, C4 and C-reactive protein in serum of all patients were measured before and after treatment using ELISA technique.The serum level of C3, C4 and C-RP were calculated as mean ± standard error of mean (SEM); paired t-test was used; S= significant, P value < 0.05 Results :The levels of C3, C4 and C-RP were significantly reduced (P< 0.05) in serum of all patients after treatment with CQP for one month. Conclusion :CQP is a disease modifying anti rheumatic drug (DMARD) used for patients suffering from KOA in order to reduce their C3, C4 and C-RP value and improves the disease status.http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1266Chloroquine phosphate, acute phase protein, knee osteoarthritis, C-reactive protein, and complement.
spellingShingle Kismat M. Turki
Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
مجلة كلية الطب
Chloroquine phosphate, acute phase protein, knee osteoarthritis, C-reactive protein, and complement.
title Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
title_full Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
title_fullStr Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
title_full_unstemmed Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
title_short Role of Chloroquine phosphate on Acute phase reactant in patients with knee osteoarthritis
title_sort role of chloroquine phosphate on acute phase reactant in patients with knee osteoarthritis
topic Chloroquine phosphate, acute phase protein, knee osteoarthritis, C-reactive protein, and complement.
url http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1266
work_keys_str_mv AT kismatmturki roleofchloroquinephosphateonacutephasereactantinpatientswithkneeosteoarthritis